XL01126 is a potent PROTAC targeting LRRK2, featuring a VHL ligand and a thiol linked to an LRRK2 inhibitor. This compound effectively crosses the blood-brain barrier and serves as a degradation probe for investigating LRRK2's non-catalytic and structural roles in Parkinson's disease research.
Usually ships within 24 hours.